U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT07477743) titled 'A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors' on March 12.
Brief Summary: Phase Ib study to evaluate the tolerability, safety, pharmacokinetics and preliminary efficacy of HC010 in combination with chemotherapy regimens in patients with advanced gastrointestinal cancer and determine the recommended dose for subsequent studies.
Study Start Date: March 17
Study Type: INTERVENTIONAL
Condition:
Advanced Solid Tumor Cancer
Intervention:
DRUG: HC010
HC010 once every 3 weeks (Q3W) by intravenous drip
DRUG: Paclitaxel
the combination chemotherapy regimens are all commonly used...